Hinweis-Modus ist eingeschaltet Ausschalten

- Amplify Treatments, Testing and Advancements ETF (USD) (US0321085815)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
US0321085815
ISIN
Exchange Traded Funds (ETF)
Fondstyp
Amplify Investments
Anbieter
19,34 USD
NAV pro Aktie | 05/09/2024
17/06/2020
Startdatum
4 Wiederholungen pro Jahr
Ausschüttung von Dividenden
CEOJMS
CFI
-
Ticker
Closed
Status
Equity
Investitionsobjekt
Healthcare
Sektor
USA
Geographie
Prime Treatments, Testing and Advancements Index
Benchmark
0.68 %
Gesamtkostenquote
9,67 Mio. USD
Gesamtes Fondsvermögen | 05/09/2024
9,67 Mio. USD
Aktien-Anlageklasse Volumen | 05/09/2024
Nein
UCITS

Letzte Daten zum
Letzte Daten zum 05/09/2024
Zum Vergleichen hinzufügen

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

Fund profile

The Amplify Treatments, Testing and Advancements ETF seeks to replicate as closely as possible the price and yield performance of the Prime Treatments, Testing and Advancements Index by investing in a portfolio comprised primarily of U.S. companies engaged in and at the forefront of R&D, vaccines, therapies and testing technologies

profile

The Amplify Treatments, Testing and Advancements ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The Amplify Investments fund’s base currency is USD and the share class was registered 17.06.2020 with unique ISIN - US0321085815. The total expense ratio is 0.68%. The Amplify Treatments, Testing and Advancements ETF (USD) pays dividends 4 time(s) per year.

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.